Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Corrigendum to "Cost-effectiveness of first-line osimertinib informed by electronic medical records via text-mining: a real-world Italian case study of EGFR-mutated advanced NSCLC patients": [ESMO Real World Data and Digital Oncology Volume 10, December 2025, 100198].
ESMO real world data and digital oncology·2026
Data analytics for real-world data integration in TKI-treated NSCLC patients using electronic health records.
ESMO real world data and digital oncology·2026
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671).
Annals of oncology : official journal of the European Society for Medical Oncology·2024